000 01478 a2200397 4500
005 20250514054742.0
264 0 _c20030130
008 200301s 0 0 eng d
022 _a0015-0282
024 7 _a10.1016/s0015-0282(02)04409-6
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBoostanfar, Robert
245 0 0 _aGrowth effects of raloxifene, estradiol, medroxy-progesterone acetate, and progesterone on human endometrial adenocarcinoma cells.
_h[electronic resource]
260 _bFertility and sterility
_cJan 2003
300 _a223-5 p.
_bdigital
500 _aPublication Type: Comparative Study; Letter
650 0 4 _aAdenocarcinoma
_xpathology
650 0 4 _aCell Division
_xdrug effects
650 0 4 _aEndometrial Neoplasms
_xpathology
650 0 4 _aEstradiol
_xpharmacology
650 0 4 _aEstrogen Replacement Therapy
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMedroxyprogesterone Acetate
_xpharmacology
650 0 4 _aProgesterone
_xpharmacology
650 0 4 _aRaloxifene Hydrochloride
_xpharmacology
650 0 4 _aSelective Estrogen Receptor Modulators
_xpharmacology
650 0 4 _aTumor Cells, Cultured
700 1 _aAmezcua, Charles A
700 1 _aTourgeman, David E
700 1 _aRoy, Subir
700 1 _aFelix, Juan C
700 1 _aStanczyk, Frank Z
773 0 _tFertility and sterility
_gvol. 79
_gno. 1
_gp. 223-5
856 4 0 _uhttps://doi.org/10.1016/s0015-0282(02)04409-6
_zAvailable from publisher's website
999 _c12326521
_d12326521